These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6283811)

  • 41. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes.
    Hara E; Kawajiri K; Tagashira Y
    Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the oxidation of hydroxyl radical scavenging agents after alkaline phosphatase treatment of rat liver microsomes.
    Puntarulo S; Cederbaum AI
    Biochim Biophys Acta; 1991 May; 1074(1):12-8. PubMed ID: 1904277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes.
    Crowell SR; Hanson-Drury S; Williams DE; Corley RA
    Toxicol Lett; 2014 Jul; 228(1):48-55. PubMed ID: 24769260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies in the metabolism of carcinogenic polycyclic heteroaromatic compounds. I. The hepatic microsomal metabolism of 7-methylbenz[c]acridine.
    Ireland CM; Holder GM; Ryan AJ
    Biochem Pharmacol; 1981 Oct; 30(19):2685-90. PubMed ID: 6271143
    [No Abstract]   [Full Text] [Related]  

  • 45. Stereoselectivity of rat liver cytochrome P-450c on formation of benzo[a]pyrene 4,5-oxide.
    Armstrong RN; Levin W; Ryan DE; Thomas PE; Mah HD; Jerina DM
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1077-84. PubMed ID: 6791642
    [No Abstract]   [Full Text] [Related]  

  • 46. Involvement of a cytosolic carrier protein fraction in the microsomal metabolism of benzo(a)pyrene in rat liver.
    Hanson-Painton O; Griffin MJ; Tang J
    Cancer Res; 1983 Sep; 43(9):4198-206. PubMed ID: 6307506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of benzo[a]pyrene with H1 histone in rat-liver nuclei.
    Kurokawa M; Sugano N
    Cancer Lett; 1983 May; 19(1):13-20. PubMed ID: 6303559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Position-specific oxygenation of benzo(a)pyrene by different forms of purified cytochrome P-450 from rabbit liver.
    Wiebel FJ; Selkirk JK; Gelboin HV; Haugen DA; van der Hoeven TA; Coon MJ
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):3917-20. PubMed ID: 1060073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benzo(a)pyrene hydroxylase from Saccharomyces cerevisiae. Substrate binding, spectral and kinetic data.
    Woods LF; Wiseman A
    Biochim Biophys Acta; 1980; 613(1):52-61. PubMed ID: 6990989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibody characterization of NADH- and NADPH-dependent hydroxylation of benzo(a)pyrene in liver microsomes from 5,6-benzoflavone-induced C57Bl/6 mice.
    Brauze D; Mikstacka R; Pelkonen O
    Acta Biochim Pol; 1990; 37(2):219-25. PubMed ID: 2072980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The direct spectrophotometric observation of benzo(a)pyrene phenol formation by liver microsomes.
    Prough RA; Patrizi VW; Estabrook RW
    Cancer Res; 1976 Dec; 36(12):4439-43. PubMed ID: 1000493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in the ratio of microsomal electron carriers in reconstituted microsomal membranes].
    Mishin VM; Grishanova AIu; Liakhovich VV
    Biokhimiia; 1984 Apr; 49(4):686-91. PubMed ID: 6428468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo activation of oxidative drug metabolism by flavonoids.
    Lasker JM; Huang MT; Conney AH
    J Pharmacol Exp Ther; 1984 Apr; 229(1):162-70. PubMed ID: 6323685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of spironolactone on drug metabolism by hepatic microsomes.
    Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
    [No Abstract]   [Full Text] [Related]  

  • 55. Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.
    Raucy JL; Johnson EF
    Mol Pharmacol; 1985 Feb; 27(2):296-301. PubMed ID: 3969073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of benzo(a)pyrene and benzo(a)pyrene 4,5-oxide in rabbit lung.
    Bend JR; Smith BR; Ball LM; Plummer JL; Wolf CR; Philpot RM; Devereux TR; Fouts JR
    Adv Exp Med Biol; 1981; 136 Pt A():541-54. PubMed ID: 6283815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations of pulmonary benzo[a]pyrene metabolism by reactive oxygen metabolites.
    Flowers NL; Miles PR
    Toxicology; 1991; 68(3):259-74. PubMed ID: 1654602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of cytochrome P-450-448 inhibitors on the binding of benzo(a)pyrene and derivatives to DNA upon microsomal activation.
    Liu WI; Sloane NH
    Xenobiotica; 1979 Mar; 9(3):165-71. PubMed ID: 38576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat.
    Schneck DW; Pritchard JF
    J Pharmacol Exp Ther; 1981 Sep; 218(3):575-81. PubMed ID: 6267246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benzo(a)pyrene metabolism by murine spleen microsomes.
    Kawabata TT; White KL
    Cancer Res; 1989 Nov; 49(21):5816-22. PubMed ID: 2507138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.